NEW YORK (GenomeWeb News) - InforSense and Linguamatics are partnering to develop an integrated text extraction and analytics platform, InforSense said today.
 
Under the agreement, Linguamatics' Interactive Information Extraction software tools will access InforSense’s text analytics platform, InforSense TextSense. The extension will provide a single environment to build tailored, high-performance text analytics applications, InforSense said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.